Rakuten CEO To Quit Advisory Panel, Sue Japan If Drug e-Sales Restricted
This article was originally published in PharmAsia News
Executive Summary
Rakuten CEO Hiroshi Mikitani said he not only would resign from a committee that has been advising Prime Minister Shinzo Abe if the administration decides to continue restrictions on sales of certain drugs, he would fight in court.